Evaluation of Circulating Chitotriosidase Activity in Children with Obesity

Ioana Țaranu1,2, Mihaela Iancu1, Cecilia Lazea2,3

  • 1Department of Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Str., No. 6, 400349 Cluj-Napoca, Romania.

Insights

Chitotriosidase (CHIT1) plasma activity is higher in children with extreme obesity, indicating it may reflect immune responses. Specific CHIT1 gene variants also influence this activity in pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Immunology
  • Metabolic Health

Background:

  • Childhood obesity is linked to low-grade inflammation and metabolic disturbances.
  • Identifying biomarkers for immune response activity is crucial for understanding obesity pathogenesis.
  • Chitotriosidase (CHIT1) is an enzyme involved in immune responses.

Purpose of the Study:

  • To investigate changes in plasma chitotriosidase (CHIT1) activity in relation to Body Mass Index (BMI)-for-age z-scores in pediatric patients.
  • To examine the influence of common CHIT1 gene variants (dup24 and G102S) on the association between CHIT1 activity and obesity levels.

Main Methods:

  • Evaluated 68 children (mean age ~12 years) with varying BMI-for-age z-scores.
  • Measured plasma chitotriosidase (CHIT1) activity.
  • Assessed the impact of CHIT1 gene variants (dup24, G102S) on CHIT1 activity and obesity correlation.
  • Utilized statistical analysis to control for age, gender, and time since weight gain.

Main Results:

  • Significantly higher logCHIT1 plasma activity was observed in children with extreme obesity compared to those with overweight (p=0.026).
  • BMI-for-age z-score significantly predicted increased CHIT1 activity in overweight, obese, and extremely obese children (p=0.031).
  • CHIT1 gene variants, dup24 and G102S, were significant independent predictors of CHIT1 plasma activity changes (p<0.002).

Conclusions:

  • Circulating chitotriosidase (CHIT1) may serve as an accurate indicator of inflammation in pediatric obesity.
  • Further validation in larger cohorts is needed to confirm the role of CHIT1 and its variants in pediatric obesity-related inflammation.

Related Concept Videos